electroCore, Inc. financial data

Symbol
ECOR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
200 Forge Way, Suite 205, Rockaway, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
ElectroCore, LLC (to 6/20/2018)
Latest financial report
10-K - Q4 2024 - Mar 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % -3.72%
Quick Ratio 27.1 % -17%
Debt-to-equity 136 % +62.1%
Return On Assets -61.1 % +44.2%
Operating Margin -48.3 % +59.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.19M shares +19.8%
Common Stock, Shares, Outstanding 6.65M shares +10.8%
Entity Public Float 22.4M USD -32.5%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 7.48M shares +35.7%
Weighted Average Number of Shares Outstanding, Diluted 7.48M shares +35.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25.2M USD +57.1%
Research and Development Expense 2.36M USD -55.6%
Operating Income (Loss) -12.2M USD +36.9%
Nonoperating Income (Expense) 183K USD -26.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12M USD +37%
Income Tax Expense (Benefit) -122K USD +42.2%
Net Income (Loss) Attributable to Parent -11.9M USD +36.9%
Earnings Per Share, Basic -1.59 USD/shares +53.5%
Earnings Per Share, Diluted -1.59 USD/shares +53.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.45M USD -66.6%
Marketable Securities, Current 8.52M USD
Cash, Cash Equivalents, and Short-term Investments 12.2M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.37M USD +90.7%
Inventory, Net 1.68M USD -22.4%
Assets, Current 16.3M USD +14%
Property, Plant and Equipment, Net 158K USD -22.5%
Operating Lease, Right-of-Use Asset 3.74M USD +645%
Other Assets, Noncurrent 274K USD -44.6%
Assets 20.5M USD +27.1%
Accounts Payable, Current 1.83M USD -15.5%
Accrued Liabilities, Current 6.96M USD +18.6%
Liabilities, Current 9.15M USD +12.7%
Operating Lease, Liability, Noncurrent 3.78M USD +603%
Liabilities 12.9M USD +49.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 114K USD
Retained Earnings (Accumulated Deficit) -177M USD -7.2%
Stockholders' Equity Attributable to Parent 7.54M USD +1.37%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8M USD -62.7%
Liabilities and Equity 20.5M USD +27.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.56M USD +56.3%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 6.65M shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.48M USD +57.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.7M USD -65%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD +150%
Deferred Tax Assets, Valuation Allowance 44.3M USD +9.24%
Deferred Tax Assets, Gross 45.5M USD +11.3%
Operating Lease, Liability 4.14M USD +561%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.7M USD +37.8%
Lessee, Operating Lease, Liability, to be Paid 10.6M USD +1111%
Operating Lease, Liability, Current 361K USD +306%
Lessee, Operating Lease, Liability, to be Paid, Year Two 530K USD +210%
Lessee, Operating Lease, Liability, to be Paid, Year One 369K USD +120%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.44M USD +2506%
Lessee, Operating Lease, Liability, to be Paid, Year Three 625K USD +288%
Deferred Tax Assets, Operating Loss Carryforwards 35.9M USD +6.78%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 649K USD +313%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 206K USD +68.9%
Deferred Tax Assets, Net of Valuation Allowance 1.15M USD +302%
Share-based Payment Arrangement, Expense 1.87M USD +10.1%
Interest Expense 2.25K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%